Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor.

Adv Sci (Weinh) · 2021 · PMC8596099 · PMID 34664430

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The result is highly significant considering the normal upper limit (35 U mL −1 ) and is supported by the marked reduction of tumor mass upon comparison of PET/CT images at diagnosis and post‐PTX+CBP treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.